2 of the counters that I am monitoring has a bullish gap.
1. 3PAR (PAR) has a bullish gap on speculation that it will be acquired.
2. Sinovac Biotech (SVA) files for a new vaccination on trials for hand, foot, mouth disease.
Got this from InvestIdeas forum.
A member highlighted an article
Chinese government support and ‘sea turtles’ are spurring the sector, but investors lack exits.
The key point highlighted in the article includes a claim that investors may lack an exit strategy despite the huge potential of the biotecfh market in China.
The article can be found here.